The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
October 2nd 2024
In May 2024, the first biosimilars for aflibercept were approved, which included aflibercept-jbvf (Yesafili; Biocon Biologics), known as MYL-1701P.
Insurance Coverage for Pregnant Women Improves for ACA Medicaid Expansion
January 11th 2022The data were used to evaluate effect of the ACA state Medicaid on insurance coverage, health care use, and health outcomes measured between 1 month prior to conception through 1 year postpartum, and neonatal outcomes within 27 days of birth.
Read More